Imunon
NASDAQ:CLSNCelsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
SustainCo Inc. (SMS.V)
CVE:SMSSustainCo Inc., through its subsidiaries, provides infrastructure solutions and services in Canada. The company develops intelligent building technology, including the integration of disparate building systems for the provision of building automation and controls, HVAC mechanical services, real-time performance monitoring, and energy efficient retrofit and solutions. It also provides heating and cooling solutions for multi-residential and commercial buildings using energy from the earth. In addition, the company offers engineering services, building automation controls, mechanical and electrical installation, performance monitoring, and operations and maintenance services for multi-residential and ICI facilities. SustainCo Inc. was incorporated in 2008 and is based in Vaughan, Canada. The company is a subsidiary of Skyvest Aviation Inc.